Companies & Industry »Company News»Company News Details
Company News Details

BSE   25 May 18 | 12:00 AM

998.00 21.8 (2.23%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532331
Face Value: N.A.

NSE   25 May 18 | 12:00 AM

998.05 20.45 (2.09%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: AJANTPHARM
Performance
1 Week : Rs 1,023.55 (-2.50%)
1 Month : Rs 1,364.30 (-26.85%)
1 Year : Rs 1,596.65 (-37.49%)
change companytradenow
Back

Ajanta Pharma gains on launch of generic SINGULAIR capsules in the US

SI Reporter / Mumbai 17 Nov 15 | 12:41 PM

Shares of Ajanta Pharma were up nearly 2% at Rs 1,358 on the Bombay Stock Exchange, after the company said announced the launch of Montelukast Sodium oral granules (4mg), a bioequivalent generic version of SINGULAIR Granules, in the US market.

The Montelukast Granules are offered in cartons containing 30 individuals sachets, the company said in release. The drug is dispensed to prevent asthma attacks.

Widgets Magazine

The approval and launch of the Monteklukast Granules is part of an ever-growing portfolio that Ajanta Pharma has developed for the US market, the release added.

The release also said that the US Food & Drug Administration (USFDA) has granted five ANDA approvals and two ANDA tentative approvals adding that an additional 19 ANDAs are pending approval from the USFDA.

The stock opened at Rs 1366 and touched a high of Rs 1,370. At 12:40pm, over 198,000 shares were traded on both the stock exchanges

Widgets Magazine

Sensex

Company Price Gain (%)
O N G C175.354.59
Tata Steel567.203.43
Yes Bank339.452.71
Adani Ports379.902.34
IndusInd Bank1,914.752.33

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine